CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer (Q38741840)

6 September 2017

title

CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer (English)

1 reference

6 September 2017

H Zhang

1

1 reference

6 September 2017

Y-L Ye

2

1 reference

6 September 2017

M-X Li

3

1 reference

6 September 2017

S-B Ye

4

1 reference

6 September 2017

W-R Huang

5

1 reference

6 September 2017

T-T Cai

6

1 reference

6 September 2017

J He

7

1 reference

6 September 2017

J-Y Peng

8

1 reference

6 September 2017

T-H Duan

9

1 reference

6 September 2017

J Cui

10

1 reference

6 September 2017

X-S Zhang

11

1 reference

6 September 2017

F-J Zhou

12

1 reference

6 September 2017

R-F Wang

13

1 reference

6 September 2017

J Li

14

1 reference

6 September 2017

language of work or name

English

0 references

publication date

10 October 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

36

1 reference

6 September 2017

issue

15

1 reference

6 September 2017

page(s)

2095-2104

1 reference

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

The future of bladder cancer care in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

The mechanism of action of BCG therapy for bladder cancer--a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Shaping of an effective immune microenvironment to and by cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

ROR1C Regulates Differentiation of Myeloid-Derived Suppressor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Stromal-dependent tumor promotion by MIF family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Myeloid-derived suppressor cells as therapeutic target in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Immunotherapy: PD-1-PD-L1 axis: efficient checkpoint blockade against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Influential Factors and Synergies for Radiation-Gene Therapy on Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.367

Epithelial-mesenchymal transition in gastric cancer

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27721403

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27721403

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of inflammation and inflammatory mediators in colorectal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27721403

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2016.367

1 reference

Dimensions Publication ID

6 September 2017

1017245809

0 references

1 reference